Free Newsletter
Register for our Free Newsletters
Zones
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Materials
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
 
 
 
 
 
 
 
 
Guides
C difficile
C difficile stands for Clostridium difficile or C diff and is a species of Gram-positive bacteria of the genus Clostridium. Clostridia are anaerobic, spore-forming rods (bacillus). C difficile is the most serious cause of antibiotic-associated diarrhoea (AAD) and can lead to pseudomembranous colitis, a severe infection of the colon, often resulting from eradication of the normal gut flora by antibiotics. The C difficile bacteria, which naturally reside in the body, become overgrown. The overgrowth can prove harmful because the bacterium releases toxins that can cause bloating, constipation, and diarrhoea with abdominal pain, which may become severe. The links shown on this page feature the key word ′C difficile’ in their stories:
Healthcare watchdog pledges to take tough action over infection control failures
The Healthcare Commission has pledged to continue tough action in NHS trusts that are failing to put adequate systems in place to tackle healthcare-associated infections.
APIC introduces new programme to help eradicate HAIs
The Association for Professionals in Infection Control and Epidemiology (APIC) has introduced a new series of educational initiatives aimed at eliminating healthcare-associated infections (HAIs).
Worcester Acute NHS Trust wins major Infection Control Award
Worcester Acute NHS Trust, UK, has won the 2007/2008 Oxoid Infection Control Team of the Year Awards.
New infection control keyboard helps combat HAIs
Devlin Electronics has released the new KCR-106-6XX infection control keyboard in the company’s healthcare range which is specifically designed to help health services tackle the problems of hospital acquired infections.
Inverness offers rapid detection of C difficile infection in a matter of minutes
Inverness Medical provides rapid detection of C difficile infection in under 30 minutes with the Techlab C. Diff Quik Chek for the detection of C difficile antigen glutamate dehydrogenase (GDH) which is common to all strains of C difficile and Techlab Tox A/B Quik Chek for detection of Toxins A and
Inverness new rapid test for C Diff associated disease
Inverness Medical has launched the new Techlab C Diff Quik Chek Complete rapid test as an in vitro diagnostic aid for Clostridium difficile associated disease (CDAD).
Cepheid releases Xpert C. difficile as a European CE IVD Mark product
Cepheid has released Xpert C. difficile as a European CE IVD Mark product under the European Directive on In Vitro Diagnostic Medical Devices.
C difficile cases continue downward trend in patients aged 65 years and over
The Health Protection Agency has reported C difficile figures which show that between July to September 2008 there were 7,061 cases recorded in patients aged 65 years and over.
APIC plans to expand Targeting Zero initiative for 2009 to prevent HAIs
The Association for Professionals in Infection Control and Epidemiology (APIC) plans to expand its successful Targeting Zero initiative for 2009 to offer comprehensive education and guidance to prevent the most common and fatal healthcare-associated infections (HAIs).
Cepheid launches fast MRSA/SA nasal detection test
Cepheid releases of the Xpert MRSA/SA Nasal test as a European CE IVD Mark product under the European Directive on In Vitro Diagnostic Medical Devices.
Health Protection Agency updates C difficile figures
The Health Protection Agency’s latest reported C difficile figures show that between October to December 2008 there were 6,257 cases recorded in patients aged 65 years and over.
Heart of England NHS Foundation Trust claims Infection Control Prize
The first prize of £5,000 in the 2008/2009 Oxoid Infection Control Team of the Year Awards is awarded to the Heart of England NHS Foundation Trust, Birmingham, England.
LABORATORY AND ANALYTICAL – ASSAY EQUIPMENT
FOCUS ZONE REPORT – A collaborative development venture between Universal Sensors, Nottingham Trent University and Cambridge Design Partnership is aiming to help in the fight against C difficile and MRSA.
Faecal management systems helps clinicians to protect patients
ConvaTec launches Flexi-Seal SIGNAL Faecal Management System (FMS) which is now available in the USA, UK and other key European markets.
C difficile test gives results within 20 minutes
Oxoid is now offering a Clostridium difficile (C difficile) test for that provides results to healthcare professionals in just 20 minutes.
HPA develops new immunotherapeutic treatment for C difficile infection (CDI)
The Health Protection Agency's annual conference, Health Protection 2010, is presenting new research which shows how an alternative approach for treating and preventing Clostridium difficile infection (CDI) is being developed by the agency's scientists.
Wound dressing with ionic silver kills several strains of highly-resistant bacteria
ConvaTec is reporting new in vitro study results showing that a wound dressing containing ionic silver is able to kill several strains of highly-resistant bacteria.
ConvaTec introduces nurse-inspired fecal management system
ConvaTec is launching and enhanced Flexi-Seal SIGNAL Fecal Management System (FMS).
University Hospital of Wales collaborates with Luminex during Olympic Games
Public Health Wales plans to use Luminex's CE marked xTAG Gastrointestinal Pathogen Panel (GPP) for outbreak investigation activities during Olympic and Paralympic training and events taking place in Wales.
IntelligentMDx receives CE-mark of a test for detection of Influenza A, Influenza B and Respiratory Syncytial Virus
IntelligentMDx (IMDx) obtains CE-marking for a multiplexed, real-time PCR test for detection and differentiation of Influenza A, Influenza B, and Respiratory Syncytial Virus.
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com